The spectrometry market is predicted to increase at a CAGR of 6.5 percent from USD 4.1 billion in 2020 to USD 5.6 billion by 2025
The spectrometry market is predicted to increase at a CAGR of 6.5 percent from USD 4.1 billion in 2020 to USD 5.6 billion by 2025.
Increasing global spending on pharmaceutical R&D, government regulations on drug safety, a growing focus on food quality, an increase in crude and shale gas production, and growing government initiatives for pollution control and environmental testing are all high growth prospects for the spectrometry market over the forecast period.
From 2020 to 2025, the
pharmaceutical industry's end-user segment is predicted to increase at the
fastest rate.
The
pharmaceutical industry, biotechnology industry, research & academic
institutes, environmental testing industry, food & beverage testing
industry, petrochemical industry, and other end users have been segmented in
the mass spectrometry market. The pharmaceutical industry is one of the most
important end-users of mass spectrometers. Some of the key factors driving the
growth of this segment during the forecast period include the availability of
government and corporate funding for pharmaceutical research, the growth of the
pharmaceutical industry, and the presence of stringent regulatory guidelines
for drug development and safety.
During the forecast
period, the hybrid mass spectrometry segment is predicted to develop at the
fastest CAGR in the mass spectrometry market.
The
foot and ankle devices market is divided into three categories: hybrid mass
spectrometry, single mass spectrometry, and other technologies. During the
projected period, the hybrid mass spectrometry segment is expected to increase
at the fastest rate. Hybrid mass spectrometers include advantages such as
speedy and high-resolution testing capabilities, as well as more accurate and
exact results are increasing its adoption. As a result, there is an increasing
demand for mass spectrometry instruments for high-throughput screening. The
Triple Quadrupole, Quadrupole ToF (Q-ToF), and Fourier Transform Mass
Spectrometry segments of hybrid mass spectrometry are further subdivided
(FTMS).
During the projection period, the life science research segment
is predicted to develop at the fastest rate.
The spectrometry market is divided into life science research,
drug development, environmental testing, food testing, applied industries,
clinical diagnostics, and other applications based on application. The
market in 2019 was dominated by the life science research segment. The market
for this category is likely to be driven by the increasing use of omics
technology in diagnostics and biomarker discovery, as well as increased R&D
expenditure and government support for proteomics.
The research contains profiles of some of the major players in
the spectrometry market to help readers have a better knowledge of the
competitive landscape. Thermo Fisher Scientific (US), SCIEX (US), Agilent
Technologies (US), Waters Corporation (US), PerkinElmer (US), Shimadzu
Corporation (Japan), Bruker (US), Analytik Jena (Germany), JEOL (Japan), Rigaku
(Japan), DANI Instruments (Italy), LECO (US), and Hiden Analytical (Japan) are
the major players in the spectrometry market (UK)These companies are employing
a variety of techniques to improve their market share in mass spectrometry.
Collaborations and partnerships, new product releases, expansions, and
acquisitions are all common strategies used by large mass spectrometry players.
Comments
Post a Comment